B-ALL
Report from ASH 2019: Large Benefit With Blinatumomab in Trial of Younger B-ALL Patients
ORLANDO, FLA.—In children, adolescents and young adults with B-cell acute lymphoblastic leukemia who have ...
DECEMBER 23, 2019
ALL Has Potential to Relapse After CAR T-Cell Therapy
B-cell acute lymphoblastic leukemia can recur when leukemic cells become resistant to chimeric antigen receptor ...
OCTOBER 26, 2018
Genetic Underpinning of ALL Subtype Uncovered
Two transcription factors, DUX4 and ERG, appear to be genetic hallmarks for a rare form of B-precursor acute ...
NOVEMBER 18, 2016
Load more